GenMark Q4 Revenues Grow 51 Percent | GenomeWeb

NEW YORK (GenomeWeb) – GenMark Diagnostics said after the close of the market on Tuesday that revenues for its fourth quarter rose 51 percent year over year. 

The Carlsbad, Calif.-based company posted revenues of $9.8 million for the three months ended Dec. 31, 2014, up from $6.5 million in the year-ago quarter, beating the consensus Wall Street estimate of $9.1 million. During the recently completed quarter, GenMark placed 38 XT-8 analyzers in end-user laboratories for a total installed base of 540 instruments in the US as of the end of 2014. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.